Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
New directors at 4D Pharma, Neurogene And Zogenix.
Plus promotions at Agios Pharmaceuticals, Bafna Pharmaceuticals, Miragen Therapeutics and Compass Therapeutics.
The former CEO of Cipla’s India business is set to steer JB Chemicals and Pharmaceuticals, as the Indian firm embarks on a new phase of growth, backed by a revamped board, following its takeover by US private equity firm KKR.
New CMOs appointed at Black Diamond Therapeutics and Dicerna Pharmaceuticals.
Two new independent directors are appointed at Bristol Myers Squibb and new CEOs are named for Immunicum, Race Oncology and Recce Pharmaceuticals.
New CEO named at Therapix Biosciences, and a new COO appointed at Elgia Therapeutics.
Swedish Orphan Biovitrum names R&D head while Regulus Therapeutics gets a new chief scientific officer and Zealand Pharma a new head of investor relations.
Oasmia Pharmaceutical and Sierra Oncology appoint chief business officers, I-Mab a chief commercial officer, and AcuCort a CEO.
New board directors named at Autolus Therapeutics, Beximco Pharmaceuticals, Tetraphase Pharmaceuticals and Vesigen.
Jörn Aldag, who has over 20 years of leadership experience in the life sciences industry, including CEO of gene therapy pioneer uniQure, tells Scrip that the research carried at the world-class Italian research institute SR-Tiget.
Also, NeuBase Therapeutics has secured a new chief operating officer and Amgen has named a new vice president-finance/chief accounting officer.
AnaptysBio secures new chief financial officer, while Tarsus Pharmaceuticals has a new chief operating officer.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.